Cyclin‐dependent kinase 5 regulates degranulation in human eosinophils

Degranulation from eosinophils in response to secretagogue stimulation is a regulated process that involves exocytosis of granule proteins through specific signalling pathways. One potential pathway is dependent on cyclin‐dependent kinase 5 (Cdk5) and its effector molecules, p35 and p39, which play a central role in neuronal cell exocytosis by phosphorylating Munc18, a regulator of SNARE binding. Emerging evidence suggests a role for Cdk5 in exocytosis in immune cells, although its role in eosinophils is not known. We sought to examine the expression of Cdk5 and its activators in human eosinophils, and to assess the role of Cdk5 in eosinophil degranulation. We used freshly isolated human eosinophils and analysed the expression of Cdk5, p35, p39 and Munc18c by Western blot, RT‐PCR, flow cytometry and immunoprecipitation. Cdk5 kinase activity was determined following eosinophil activation. Cdk5 inhibitors were used (roscovitine, AT7519 and small interfering RNA) to determine its role in eosinophil peroxidase (EPX) secretion. Cdk5 was expressed in association with Munc18c, p35 and p39, and phosphorylated following human eosinophil activation with eotaxin/CCL11, platelet‐activating factor, and secretory IgA‐Sepharose. Cdk5 inhibitors (roscovitine, AT7519) reduced EPX release when cells were stimulated by PMA or secretory IgA. In assays using small interfering RNA knock‐down of Cdk5 expression in human eosinophils, we observed inhibition of EPX release. Our findings suggest that in activated eosinophils, Cdk5 is phosphorylated and binds to Munc18c, resulting in Munc18c release from syntaxin‐4, allowing SNARE binding and vesicle fusion, with subsequent eosinophil degranulation. Our work identifies a novel role for Cdk5 in eosinophil mediator release by agonist‐induced degranulation.

[1]  C. Lam,et al.  MicroRNA-21* regulates the prosurvival effect of GM-CSF on human eosinophils. , 2013, Immunobiology.

[2]  E. Chilvers,et al.  Effects of the cyclin‐dependent kinase inhibitor R‐roscovitine on eosinophil survival and clearance , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  P. Kaldis,et al.  Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms , 2009, Oncogene.

[4]  C. Haslett,et al.  The CDK inhibitor, R‐roscovitine, promotes eosinophil apoptosis by down‐regulation of Mcl‐1 , 2009, FEBS letters.

[5]  Paul G Wyatt,et al.  Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design. , 2008, Journal of medicinal chemistry.

[6]  S. Phipps,et al.  Eosinophils: Biological Properties and Role in Health and Disease , 2008, Clinical and Experimental Allergy.

[7]  M. Rajadhyaksha,et al.  An Unusual Member of the Cdk Family: Cdk5 , 2008, Cellular and Molecular Neurobiology.

[8]  P. Workman,et al.  The Cyclin-Dependent Kinase Inhibitor Seliciclib (R-roscovitine; CYC202) Decreases the Expression of Mitotic Control Genes and Prevents Entry into Mitosis , 2007, Cell cycle.

[9]  B. Davletov,et al.  Munc18-1 is critical for plasma membrane localization of syntaxin1 but not of SNAP-25 in PC12 cells. , 2007, Molecular biology of the cell.

[10]  T. Colby,et al.  Coexpression of IL-5 and Eotaxin-2 in Mice Creates an Eosinophil-Dependent Model of Respiratory Inflammation with Characteristics of Severe Asthma1 , 2007, The Journal of Immunology.

[11]  J. Stow,et al.  SNAREing immunity: the role of SNAREs in the immune system , 2006, Nature Reviews Immunology.

[12]  D. James,et al.  Molecular Dissection of the Munc18c/Syntaxin4 Interaction: Implications for Regulation of Membrane Trafficking , 2006, Traffic.

[13]  J. Rosales,et al.  Extraneuronal roles of cyclin‐dependent kinase 5 , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  H. Kita,et al.  A critical role for vesicle‐associated membrane protein‐7 in exocytosis from human eosinophils and neutrophils , 2006, Allergy.

[15]  K. Ishihara,et al.  Mechanism of the Eosinophilic Differentiation of HL-60 Clone 15 Cells Induced by n-Butyrate , 2005, International Archives of Allergy and Immunology.

[16]  J. Ernst,et al.  GTP-dependent Secretion from Neutrophils Is Regulated by Cdk5* , 2004, Journal of Biological Chemistry.

[17]  A. Ghahary,et al.  Cutting Edge: Human Eosinophils Regulate T Cell Subset Selection through Indoleamine 2,3-Dioxygenase1 , 2004, The Journal of Immunology.

[18]  Paige Lacy,et al.  The induction of eosinophil peroxidase release: improved methods of measurement and stimulation. , 2004, Journal of immunological methods.

[19]  J. Gromada,et al.  Cyclin-dependent Kinase 5 Associated with p39 Promotes Munc18-1 Phosphorylation and Ca2+-dependent Exocytosis* , 2004, Journal of Biological Chemistry.

[20]  Lauren Cohn,et al.  Asthma: mechanisms of disease persistence and progression. , 2004, Annual review of immunology.

[21]  Paige Lacy,et al.  Eosinophil function in allergic inflammation: From bone marrow to tissue response , 2004, Current allergy and asthma reports.

[22]  Isabel R Schlaepfer,et al.  Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance Published, JLR Papers in Press, April 16, 2003. DOI 10.1194/jlr.M300003-JLR200 , 2003, Journal of Lipid Research.

[23]  M. Verhage,et al.  Vesicle trafficking: pleasure and pain from SM genes. , 2003, Trends in cell biology.

[24]  T. Südhof,et al.  Sly1 binds to Golgi and ER syntaxins via a conserved N-terminal peptide motif. , 2002, Developmental cell.

[25]  Paige Lacy,et al.  Expression of eosinophil target SNAREs as potential cognate receptors for vesicle-associated membrane protein-2 in exocytosis. , 2002, The Journal of allergy and clinical immunology.

[26]  Li-Huei Tsai,et al.  A decade of CDK5 , 2001, Nature Reviews Molecular Cell Biology.

[27]  P. Berggren,et al.  Cyclin-dependent Kinase 5 Promotes Insulin Exocytosis* , 2001, The Journal of Biological Chemistry.

[28]  F. Chen,et al.  Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation. , 2001, Blood.

[29]  Paige Lacy,et al.  Fusion protein vesicle-associated membrane protein 2 is implicated in IFN-gamma-induced piecemeal degranulation in human eosinophils from atopic individuals. , 2001, The Journal of allergy and clinical immunology.

[30]  L. Tsai,et al.  Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.

[31]  T. Südhof,et al.  Synaptic assembly of the brain in the absence of neurotransmitter secretion. , 2000, Science.

[32]  S. Esnault,et al.  Primary peripheral blood eosinophils rapidly degrade transfected granulocyte-macrophage colony-stimulating factor mRNA. , 1999, Journal of immunology.

[33]  H. Pant,et al.  Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Novick,et al.  Sec1p Binds to Snare Complexes and Concentrates at Sites of Secretion , 1999, The Journal of cell biology.

[35]  R. Hosono,et al.  Regulation of the UNC-18–Caenorhabditis elegansSyntaxin Complex by UNC-13 , 1999, The Journal of Neuroscience.

[36]  A. Houng,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Human Platelets Contain SNARE Proteins and a Sec1p Homologue That Interacts With Syntaxin 4 and Is Phosphorylated After Thrombin Activation: Implications for Platelet Secretion , 1999 .

[37]  E. Stuenkel,et al.  Regulation of Exocytosis by Cyclin-dependent Kinase 5 via Phosphorylation of Munc18* , 1999, The Journal of Biological Chemistry.

[38]  D. Wong,et al.  Optimized conditions for gene transfection into the human eosinophilic cell line EoL-1 by electroporation. , 1998, Journal of immunological methods.

[39]  P. Jeffrey,et al.  Structural basis of cyclin-dependent kinase activation by phosphorylation , 1996, Nature Structural Biology.

[40]  R. Aebersold,et al.  A brain-specific activator of cyclin-dependent kinase 5 , 1994, Nature.

[41]  J. Testa,et al.  Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60 , 1984, The Journal of experimental medicine.

[42]  F. Meunier,et al.  Munc18a: Munc-y business in mediating exocytosis. , 2007, The international journal of biochemistry & cell biology.

[43]  J. Gromada,et al.  Cyclin-dependent Kinase 5 Associated with p39 Promotes Munc18-1 Phosphorylation and Ca 2 (cid:1) -dependent Exocytosis* , 2004 .

[44]  J. Gromada,et al.  Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis. , 2004, The Journal of biological chemistry.

[45]  J. Littleton,et al.  ROP, the Drosophila Sec1 homolog, interacts with syntaxin and regulates neurotransmitter release in a dosage‐dependent manner , 1998, The EMBO journal.

[46]  D O Morgan,et al.  Cyclin-dependent kinases: engines, clocks, and microprocessors. , 1997, Annual review of cell and developmental biology.